Pet Diabetes Care Market Size & Growth Forecast 2027–2036, By Segments (Distribution Channel, Animal Type, Solution), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Pet Diabetes Care Market size was assessed at USD 2.5 billion in 2026 and is poised to grow at a 8.93% CAGR between 2027 and 2036, exceeding USD 5.88 billion by 2036. The industry revenue for 2027 is estimated at USD 2.69 billion.

• Base Year Value (2026): USD 2.5 billion
• CAGR (2027-2036): 8.93%
• Forecast Year Value (2036): USD 5.88 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Pet Diabetes Care Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds 42.40% share due to high pet ownership, strong disease awareness, established veterinary care systems, and consistent use of insulin therapy and glucose monitoring solutions.
  • Asia Pacific is growing at 10.17% CAGR, supported by rising pet adoption, improving veterinary access, and increasing structured diagnosis and long-term management of pet diabetes conditions.

• Segment Momentum:

  • Veterinary hospitals and clinics lead with 43.46% share in 2026 due to their central role in diagnosis, insulin initiation, and ongoing treatment supervision requiring professional veterinary oversight.
  • Cats are the fastest-growing segment as improving veterinary awareness and owner willingness to manage feline metabolic conditions increases adoption of diagnostics, monitoring, and long-term diabetes care.

• Market Expansion Drivers:

  • Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand.
  • Growing pet insurance adoption improving affordability of long-term diabetic care solutions.
  • Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption.

• Leading Market Participants:

  Key companies in the pet diabetes care market include Zoetis Inc. (United States), Merck Animal Health (United States), Boehringer Ingelheim International GmbH (Germany), Becton, Dickinson and Company (United States), Nova Biomedical Corporation (United States), I-SENS, Inc. (South Korea), Allison Medical, Inc. (United States), Abbott Laboratories (United States), Elanco Animal Health Incorporated (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 2.5 billion
  • 2027 Estimated Market Size: USD 2.69 billion.
  • Projected Market Size: USD 5.88 billion by 2036
  • Growth Forecasts: 8.93% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Veterinary Hospitals & Clinics (Distribution Channel) | Dogs (Animal Type) | Treatment (Solution)
  • Emerging Opportunity Segment: E-commerce (Distribution Channel) | Cats (Animal Type) | Glucose Monitoring Devices (Solution)

Market Growth Drivers and Industry Trends

Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand

Rising prevalence of diabetes and chronic illnesses in companion animals will drive the pet diabetes care market as veterinarians and pet owners increasingly require solutions for disease diagnosis, glucose monitoring, insulin administration, and long-term condition management. Diabetes requires consistent monitoring and treatment to maintain appropriate glucose control and reduce the risk of complications, creating recurring demand for veterinary medicines, testing supplies, and monitoring technologies. Greater recognition of chronic metabolic conditions in pets is also encouraging owners to seek professional veterinary support and structured disease-management routines.

Growing pet insurance adoption improving affordability of long-term diabetic care solutions

Growing pet insurance adoption is supporting the pet diabetes care market by improving the financial accessibility of recurring diagnostic, monitoring, and treatment requirements associated with diabetes management. Long-term diabetic care can involve regular veterinary consultations, glucose testing, medications, and specialized monitoring, making affordability an important consideration for pet owners. Insurance coverage can help reduce the direct financial burden of eligible veterinary services and encourage owners to pursue recommended care rather than delaying diagnostic evaluations or ongoing disease-management procedures.

Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption

Expanding companion animal ownership and rising veterinary healthcare spending will boost the pet diabetes care market by increasing the willingness of owners to invest in technologies that support routine disease monitoring. As pets become more closely integrated into households, owners are placing greater emphasis on preventive care, chronic disease management, and quality of life. Monitoring devices can provide useful information about glucose levels and treatment response, supporting veterinarians and owners in making informed adjustments to ongoing care while reducing reliance on occasional clinical measurements alone.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand	2.00%	Moderate	North America, Europe	High	Near Term
Growing pet insurance adoption improving affordability of long-term diabetic care solutions	1.70%	Moderate	North America, Asia Pacific	High	Mid Term
Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption	1.40%	Low	Asia Pacific, Latin America	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America accounted for the largest share of the pet diabetes care market at 42.40% in 2026, supported by high pet ownership, advanced veterinary healthcare infrastructure, and growing awareness of chronic disease management in companion animals. Increasing willingness among pet owners to invest in long-term veterinary care is supporting demand for diabetes diagnosis, monitoring, and treatment solutions. Greater emphasis on preventive veterinary services and improved access to specialized animal healthcare further reinforces the region’s market leadership.

Asia Pacific is the fastest-growing region, supported by rising companion animal ownership, expanding veterinary service networks, and increasing awareness of pet health management. Urbanization and changing attitudes toward pets are encouraging owners to seek more comprehensive care for chronic conditions. Improvements in veterinary diagnostic capabilities and broader access to specialized treatments are also creating favorable conditions for the adoption of diabetes care solutions.

Key Country Insights

United States

Advanced Companion Care

The U.S. market emphasizes continuous glucose monitoring, insulin management, and digital veterinary care for companion animals. Clinics across the U.S. are expanding preventive diabetes management services while pet owners increasingly seek convenient monitoring solutions that improve long-term treatment adherence.

Japan

Aging Pet Support

Japan focuses on diabetes care solutions suited to its growing aging companion animal population. Veterinary practices in Japan are adopting minimally invasive monitoring methods and personalized treatment approaches that improve routine disease management for elderly pets.

South Korea

Digital Veterinary Adoption

South Korea is strengthening pet diabetes management through connected veterinary services and growing acceptance of digital monitoring technologies. Companion animal clinics are expanding access to diagnostic tools and owner education that support more consistent diabetes care.

Germany

Precision Veterinary Management

Germany prioritizes evidence-based veterinary diabetes care supported by advanced diagnostic practices and structured treatment protocols. German veterinary providers are integrating reliable monitoring technologies and tailored insulin therapies to strengthen chronic disease management for diabetic pets.

France

Preventive Veterinary Focus

France emphasizes earlier diagnosis and structured follow-up for diabetic companion animals through established veterinary care networks. French clinics continue incorporating modern glucose monitoring technologies to improve treatment planning and long-term patient outcomes.

Italy

Specialized Clinical Care

Italy is expanding access to specialized veterinary endocrinology services for companion animals requiring long-term diabetes management. Veterinary professionals in Italy are increasing the use of advanced diagnostics and individualized treatment plans to improve disease control.

Segment Leadership and Growth Trends

 

Distribution Channel Segment Analysis: Veterinary Hospitals & Clinics (Largest Segment) vs E-commerce (Fastest-Growing Segment)

Veterinary hospitals & clinics dominated the pet diabetes care market with a 43.46% share in 2026, supported by their central role in diagnosing diabetes, establishing treatment plans, monitoring glucose levels, and managing ongoing therapy for companion animals. Diabetes care often requires professional assessment and individualized treatment adjustments, making veterinary facilities an important channel for medications, monitoring products, and related care services. Their ability to combine diagnosis, treatment, follow-up examinations, and professional guidance within one setting reinforces their importance, particularly for owners seeking structured management of chronic pet conditions.

E-commerce is expanding more rapidly as pet owners increasingly seek convenient access to diabetes care products and recurring treatment supplies. Online purchasing enables owners to compare products, reorder essential items, and access specialized pet healthcare supplies without relying exclusively on physical veterinary or retail locations. Greater digital adoption among pet owners and the convenience of home delivery further support this channel's development. As diabetes management often involves continuing access to care products, e-commerce platforms can provide a practical purchasing option that complements veterinary-led treatment.

Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)

The dogs segment held the largest share of the pet diabetes care market in 2026, reflecting the substantial demand for diabetes management solutions within canine healthcare. Dogs diagnosed with diabetes require sustained monitoring and treatment, creating recurring demand for veterinary care, medications, glucose-management products, and supportive services. Increased awareness of chronic disease management among pet owners is also encouraging earlier diagnosis and more consistent treatment. The growing emphasis on companion-animal wellness and preventive veterinary care further supports the established position of dogs within the market.

Cats represent the fastest-growing animal type segment as awareness of feline diabetes and its management continues to strengthen. Improved recognition of metabolic disorders among cat owners is encouraging greater use of veterinary diagnostics and ongoing disease-management solutions. The increasing willingness of owners to pursue comprehensive care for chronic conditions is also supporting demand for monitoring and treatment options tailored to feline needs. As veterinary practices place greater emphasis on early detection and long-term management, the cat segment is gaining momentum within the broader pet diabetes care landscape.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Distribution Channel	Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce	Veterinary Hospitals & Clinics	E-commerce
Animal Type	Dogs, Cats	Dogs	Cats
Solution	Treatment, Glucose Monitoring Devices	Treatment	Glucose Monitoring Devices

Competitive Landscape and Market Positioning

Key companies in the pet diabetes care market:

1. Zoetis Inc. (United States)

2. Merck Animal Health (United States)

3. Boehringer Ingelheim International GmbH (Germany)

4. Becton Dickinson and Company (United States)

5. Nova Biomedical Corporation (United States)

6. I-SENS Inc. (South Korea)

7. Allison Medical Inc. (United States)

8. Abbott Laboratories (United States)

9. Elanco Animal Health Incorporated (United States)

Rising awareness regarding chronic pet health conditions is driving innovation in the pet diabetes care market. Manufacturers are introducing advanced glucose monitoring solutions, insulin delivery systems, and specialized nutritional products tailored for companion animals. Growing expenditure on veterinary healthcare and preventive treatment solutions is also encouraging continuous expansion of diabetes management offerings in the market.

Industry Development/News

Company Name	Date	Key Development
Boehringer Ingelheim	Aug-23	The FDA authorized SENVELGO (velagliflozin), a novel oral SGLT2 inhibitor for the management of feline diabetes. By offering a convenient once-daily liquid formulation, the drug represents a significant therapeutic innovation that reduces the frequency of insulin injections, addressing a critical compliance barrier in pet care and establishing a new standard for glucose regulation in diabetic cats.
Zoetis	Sep-22	Zoetis acquired NewMetrica, a UK-based developer of health-related quality-of-life assessment tools for pets. This acquisition integrates specialized digital monitoring capabilities into Zoetis’s existing pet health portfolio, enabling more precise clinical assessment and improved outcomes for chronic condition management, including diabetes care, through advanced data-driven veterinary diagnostics.